Central Africa is facing an alarming resurgence of the Ebola virus. According to figures published on November 2, 2026, by the Africa CDC, the ongoing epidemic already totals "10,444 confirmed cases" and has caused the death of "more than 5,300 people," mainly in the Democratic Republic of Congo (DRC), showing a case fatality rate of over 50%. This epidemic wave presents a major virological complexity: the current predominant strain is the Bundibugyo virus, against which the conventional Ervebo vaccine—although approved for Zaire ebolavirus—does not provide adequate protection.
This synthesis compares media coverage and flags blind spots, biases and conflicts of interest around this topic.
Read the full synthesis